Skip to main content
. 2014 Aug 5;16(8):e13079. doi: 10.5812/ircmj.13079

Table 3. Response to Treatment and the Incidence of Nausea and Vomiting a.

Variable Group A (n = 27), 4 mg of Ondansetron Group B (n = 27), 8 mg of Ondansetron Group C (n = 29), 0.4 mg/kg of Meperidine
Response to Treatment 16 (59) 22 (81) b 25 (86) b
Nausea and Vomiting 3 (11) c 0 (0) c 10 (34)

a Data are presented as No. (%).

b P ˂ 0.05 versus group A.

c P ˂ 0.05 versus the group C.